Plasma protein carbonylation in chronic uremia

Journal of Nephrology

Volumn 24, Issue 4, 2011, Pages 453-464

  Pavone, Barbara ^a,b   Sirolli, Vittorio ^a   Giardinelli, Annalisa ^a   Bucci, Sonia ^a   Forlì, Federica ^a   di Cesare, Moreno ^a   Sacchetta, Paolo ^a   di Pietro, Natalia ^a   Pandolfi, Assunta ^a   Urbani, Andrea ^b,c   Bonomini, Mario ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Albumin; Atherogenesis; Carbonylation; Hemodialysis; Proteomics; Uremia

Indexed keywords

CARBONYL DERIVATIVE; HUMAN SERUM ALBUMIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PLASMA PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; ATHEROGENESIS; CELL ADHESION; CHEMICAL STRESS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; PROTEIN TARGETING; UREMIA;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CELLS, CULTURED; CHRONIC DISEASE; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTEIN CARBONYLATION; RENAL DIALYSIS; RNA, MESSENGER; SERUM ALBUMIN; UREMIA; VASCULAR CELL ADHESION MOLECULE-1; VEINS;

EID: 79960392126     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.8342     Document Type: Article

References (53)

1. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
2. Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 2000;28:1708-1716.
3. Metz TO, Alderson NL, Chachich ME, Thorpe SR, Baynes JW. Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications. J Biol Chem. 2003;278:42012-42019.
4. Rhodes J. Covalent chemical events in immune induction: Fundamental and therapeutic aspects. Immunol Today. 1996;17:436-441.
5. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999;55:389-399.
6. Miyata T, Saito A, Kurokawa K, van Ypersele de Strihou C. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity. Nephrol Dial Transplant. 2001;16(Suppl 4):8-11.
7. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int. 2002;61:375-386.
8. Kakuta T, Tanaka R, Satoh Y, et al. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats. Kidney Int. 2005;68:1326-1336.
9. Dalle Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006;10:389-406.
10. Aldini G, Dalle Donne I, Maffei Facino R, Milzani A, Carini M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev. 2007;27:817-868.
11. Miyata T, Ueda Y, Yamada Y, et al. Carbonyl stress in uremia: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product. J Am Soc Nephrol. 1998;9:2349-2356.
12. Niwa T, Takeda N, Miyazaki T, et al. Elevated serum levels of 3 deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients. Nephron. 1995;69:438-443.
13. Odani H, Shinzato T, Usami J, et al. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia. FEBS Lett. 1998;427:381-385.
14. Mayer B, Zitta S, Greilberger J, et al. Effect of hemodialysis on the antioxidative properties of serum. Biochim Biophys Acta. 2003;1638:267-272.
15. Ward RA, Ouseph R, McLeish KR. Effects of high-flux hemodialysis on oxidant stress. Kidney Int. 2003;63:353-359.
16. Dursun E, Dursun B, Suleymanlar G, Ozben T. Effect of hemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol. 2005;42:123-128.
17. Dursun E, Dursun B, Suleymanlar G, Ozben T. Carbonyl stress in chronic renal failure: the effect of hemodialysis. Ann Clin Biochem. 2005;42:64-66.
18. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 2001;60:358-363.
19. Michelis R, Gery R, Sela S, et al. Carbonyl stress induced by intravenous iron during hemodialysis. Nephrol Dial Transplant. 2003;18:924-930.
20. Pandolfi A, Di Pietro N, Sirolli V, et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol. 2007;213:699-709.
21. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med. 1999;340:115-126.
22. Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes B, Barret W. Differences among techniques for high-abundant protein depletion. Proteomics. 2005;5:3304-3313.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
24. Reinheckel T, Körn S, Möhring S, Augustin W, Halangk W, Schild L. Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/ reoxygenation in isolated rat liver mitochondria. Arch Biochem Biophys. 2000;376:59-65.
25. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68:850-858.
26. Mortz E, Krogh TN, Vorum H, Görg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics. 2001;1:1359-1363.
27. Rashid G, Benchetrit S, Fishman D, Bernheim J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 2004;66:1099-1106.
28. Gorfien S, Spector A, DeLuca D, Weiss S. Growth and physiological functions of vascular endothelial cells in a new serum-free medium (SFM). Exp Cell Res. 1993;206:291-301.
29. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003;12:593-598.
30. Jadoul M, Ueda Y, Yasuda Y, et al. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress". Kidney Int. 1999;55:2487-2492.
31. Canestrari F, Galli F, Giorgini A, et al. Erythrocyte redox state in uremia anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol. 1994;91:187-193.
32. Yeung JH. Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat. Methods Find Exp Clin Pharmacol. 1991;13:23-28.
33. Bordoni V, Piroddi M, Galli F, et al. Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif. 2006;24:149-156.
34. Bonomini M, Stuard S, Carreno M-P, et al. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron. 1997;75:402-411.
35. Klein JB, McLeish KR, Ward RA. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am J Kidney Dis. 1999;33:483-491.
36. Miyata T, Kurokawa K, Van Ypersele de Strihou C. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol. 2000;11:1744-1752.
37. Bruschi M, Petretto A, Candiano G, et al. Determination of the oxido-redox status of plasma albumin in hemodialysis patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;864:29-37.
38. Jana CK, Das N, Sohal RS. Specificity of age-related carbonylation of plasma proteins in the mouse and rat. Arch Biochem Biophys. 2002;397:433-439.
39. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci. 2000;899:191-208.
40. Rottoli P, Magri B, Cianti R, et al. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics. 2005;5:2612-2618.
41. Kang JH, Kim KS, Choi SY, Know HY, Won MH. Oxidative modification of human ceruloplasmin by peroxyl radicals. Biochim Biophys Acta. 2001;1568:30-36.
42. Miller YI, Altamentova SM, Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stem from a heme initiated globin radical: antioxidant role of haptoglobin. Biochemistry. 1997;36:12189-12198.
43. Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269:9889-9897.
44. Akhand AA, Kato M, Suzuki H, et al. Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60e-Sre. J Cell Biochem. 1999;72:1-7.
45. Zoccali C, Mallamaci F, Tripepi G. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant. 2000;15:7-11.
46. Panuccio V, Mallamaci F, Tripepi G, et al. Low parathyroid hormone and pentosidine in hemodialysis patients. Am J Kidney Dis. 2002;40:810-815.
47. Lim PS, Cheng YM, Yang SM. Impairments of the biological properties of serum albumin in patients on hemodialysis. Nephrology (Carlton). 2007;12:18-24.
48. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697-701.
49. Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Contrib Nephrol. 1998;124:166-189.
50. Bonomini M, Reale M, Santarelli P, et al. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron. 1998;79:399-407.
51. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol. 2004;15:1495-1503.
52. Marques M, Sacristàn D, Mateos-Càceres PJ, et al. Different protein expression in normal and dysfunctional platelets from uremic patients. J Nephrol. 2010;23:90-101.
53. Galli F. Protein damage and inflammation in uremia and dialysis patients. Nephrol Dial Transplant. 2007;22(Suppl. 5):v20-v36.